Start-Up News November 2007

Noteworthy news from medtech start-ups, including Actuality Medical's dynamic adaptive therapy for brachytherapy and other indications; WaveBlend's new platform for aesthetic treatments; new spine products from US Spine.

Imagine that the GPS (global positioning system) in your car was required to take you to a destination, but that the destination kept changing, mid-course. That, says Michael Goldstein, president & CEO of Actuality Medical Inc. is the challenge that faces surgeons and radiation oncologists treating cancers of soft tissues like the prostate or the breast. Speaking at the In3 meeting in Boston in October 2007, Goldstein explained that tissue moves in the interval between pretreatment planning sessions and an actual procedure, and it also deforms and moves during the procedure. A solution to this problem, common to many types of cancers, was the basis for the successful initial public offering of TomoTherapy Inc., which raised $187 million in May 2007. [See Deal] on the strength of its image-guided radiation platform for increasing the precision of external beam radiation. Now, Actuality Medical aims to bring the same kind of precision and control to minimally invasive procedures, beginning with brachytherapy for prostate cancer. ( See Exhibit 1.)

For some 240,000 diagnosed prostate cancer patients, the decision about the initial treatment rests as much on adverse events as...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By 

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight

Court Orders US FDA To Return Trial Diversity Action Plan Guidance To Website

 
• By 

HHS and its agencies violated the law by swiftly implementing “sweeping and poorly thought-through directives that ordered the bulk removal of healthcare resources,” including FDA draft guidances on diversity action plans and sex differences in clinical trials, a federal court said.

Planning To Take Part in MDUFA? FDA Wants To Hear From You

 

The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.

Global Medtech Guidance Tracker: June 2025

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 50 documents have been posted on the tracker since its last update.